GC Kahn
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 13
- Plant-based Medicinal Research 4
- Drug-Induced Hepatotoxicity and Protection 3
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 3
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 3
- Oncology top 10%
- Cancer Treatment and Pharmacology 4
- Drug Transport and Resistance Mechanisms 3
- Toxicology top 10%
-
- Analytical Chemistry and Chromatography 3
GC Kahn
18 papers receiving 820 citations
Peers
Comparison fields: 5 of 83
- Pharmacology 529
- Biochemistry 99
- Clinical Biochemistry 91
- Oncology 248
- Toxicology 28
Countries citing papers authored by GC Kahn
This map shows the geographic impact of GC Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GC Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GC Kahn more than expected).
Fields of papers citing papers by GC Kahn
This network shows the impact of papers produced by GC Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GC Kahn. The network helps show where GC Kahn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside GC Kahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 1989 | 60 | |
| 3 | 1987 | 9 | |
| 4 | 1986 | 30 | |
| 5 | 1985 | 49 | |
| 6 | 1985 | 31 | |
| 7 | 1983 | 59 | |
| 8 | 1982 | 27 | |
| 9 | 1982 | 56 | |
| 10 | 1981 | 78 | |
| 11 | 1981 | 14 | |
| 12 | 1981 | 62 | |
| 13 | 1981 | 80 | |
| 14 | 1981 | 15 | |
| 15 | 1980 | 35 | |
| 16 | 1980 | 136 | |
| 17 | 1980 | 14 | |
| 18 | Biphasic Michaelis-Menten kinetics for ethoxycoumarin and phenacetin metabolism by human and rat hepatic monooxygenases [proceedings]. | 1979 | 1 |
| 19 | 1978 | 129 | |
| 20 | A comparison of dermal sensitivity to preservative and local anesthetic drugs. | 1971 | 7 |
About GC Kahn
GC Kahn is a scholar working on Pharmacology, Clinical Biochemistry, Biochemistry, Transplantation and Oncology, having authored 20 papers that have together received 892 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Cancer Treatment and Pharmacology (4 papers), Plant-based Medicinal Research (4 papers), Analytical Chemistry and Chromatography (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Metabolism and Genetic Disorders (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Pharmacology (529 citations), Biochemistry (99 citations), Clinical Biochemistry (91 citations), Oncology (248 citations) and Toxicology (28 citations). GC Kahn has collaborated with scholars based in United Kingdom, United States and Philippines. Frequent co-authors include Alan R. Boobis, MJ Brodie, DS Davies, Sandra Murray, M.R. Bending, C. T. Dollery, D. S. Davies, Donald S. Davies, Martin J. Brodie and Eugene Eisenberg. Their work appears in journals such as British Journal of Clinical Pharmacology, Xenobiotica, Biochemical Pharmacology, Analytical Biochemistry and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.